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In recent years we have been increasingly aware of patients presenting with severe 
abnormal photosensitivity recurrently affecting fixed and limited areas, which can be 
provoked at these sites through phototesting. Monochromator phototesting has shown 
severely abnormal photosensitivity across a broadspectrum of wavebands but only at 
affected sites. We have thus coined the term Broadspectrum Abnormal Localised 
Photosensitivity Syndrome (BALPS) as a more accurate name. We have since realized this 
condition has been described in the past and termed ‘fixed sunlight sensitivity’(FSS). We 
hope our suggested new diagnostic term better describes the clinical and photobiological 
features of this condition and should lead to increased recognition. We retrospectively 
studied 10 cases of BALPS seen through three specialist photodiagnostic units over a seven-
year period in order to investigate their clinical characteristics, photodiagnostic 
investigations and histopathological findings to enable phenotyping of this patient 
cohort(extended methods, see supplement).   
Eight of 10 patients were female. Mean age of onset was 37 years with mean time to 
presentation eight years following symptom onset. Limbs were a commonly affected site. 
Clinical features included erythema, oedema, blistering, intense burning sensation and 
pruritus(see Table 1 and supplement for further clinical features). Phototesting(detailed 
phototesting, Table 1) showed broad-spectrum sensitivity at the affected sites with either 
normal or markedly less sensitivity noted at sites adjacent to these areas or at unaffected 
sites at 24 hours post irradiation(figure 1). Common histopathologic findings were of 
epidermal spongiosis with lymphocyte exocytosis, mild dermal oedema and perivascular 








‘Fixed sunlight sensitivity’(FSS) was first reported in 1975 by Emmet, describing a case of 
itchy, erythematous papular rash localised to sun-exposed sites on the face, reproduced by 
photoprovocation with longwave ultraviolet light
1
. Since then a handful of reports detail a 
similar clinical pattern, where triggers including food and drugs excluded and only sunlight 
remaining
2-4
. Emmett noted the difficulty in classifying this condition as it shares various 
characteristics with well recognised photodermatoses. One suggestion is to consider this as 
a localised form of CAD, given some similarities in phototesting and histopathology. 
However, typical photodistributed sites were not involved in our patients and only 
reproducible bizarrely localised sites were affected. In one of our patients UVA alone 
appeared to trigger the eruption, suggesting similarities to polymorphic light eruption, 
however, the clinical features did not correlate. 
BALPS is also akin to a fixed drug eruption (FDE) given the localised recurrent nature, hence 
the term FSS used in the literature. In contrast to FDE we have not noted 
hyperpigmentation, nor could we incriminate any culprit drugs. Immunological memory is 
thought to be the pathogenesis implicated in FDE, with CD8+ T cells residing along the 




There may be a shared underlying pathogenesis in the form of a currently unidentified 
chromophore depositing in the skin of these patients, which absorbs the relevant 
wavelengths required to trigger a localised reaction. Due to the similar yet varied 
presentation of these cases, we wished to group them within this diagnostic entity of BALPS. 
We report on this diagnostic entity in order to raise awareness and facilitate identification 








Figure 1  
BALPS. Localised and fixed photosensitivity, only affecting right lower leg, with other sites 
unaffected. Monochromator phototesting on affected sites showed abnormal delayed 
erythema in UVB and UVA wavebands, 24 h after irradiation. UVA provocation testing on 
the affected site was markedly abnormal (grade 3 erythema) at 5J/cm
2
. (Case 4, see 
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 Subjective:  
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Table 1. Clinical features and phototesting results of patients with BALPS. 
&
Within population reference range. *Photoprotection advice includes behavioural 
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